Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328

Q3 FY25 results · Oct–Dec 2024

Krsnaa Diagnostics reported revenue from operations of ₹174.51 crore (up 10.2% from Q3 FY24) and net profit of ₹19.41 crore (up 49.6% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY25Q3 FY24YoYQ2 FY25QoQ
Revenue from operations174.51158.32+10.2%186.34−6.3%
Other income9.244.08+126.5%4.59+101.1%
Total income183.75162.40+13.1%190.93−3.8%
Profit before tax25.4816.09+58.3%25.40+0.3%
Net profit for the period19.4112.97+49.6%19.60−0.9%
EPS, basic (₹)6.014.09+46.9%6.07−1.0%
Net margin (%)11.18.210.5
Standalone · ₹ crore
ItemQ3 FY25Q3 FY24YoYQ2 FY25QoQ
Revenue from operations165.16151.55+9.0%178.72−7.6%
Other income9.294.08+127.8%4.60+101.8%
Total income174.45155.63+12.1%183.33−4.8%
Profit before tax28.3716.87+68.2%28.50−0.5%
Net profit for the period21.6013.59+59.0%21.96−1.7%
EPS, basic (₹)6.694.28+56.3%6.80−1.6%
Net margin (%)13.19.012.3
Consolidated
Filed with BSE
12 Feb 2025, 18:39 IST
Board meeting
12 Feb 2025
Period
01 Oct 2024 to 31 Dec 2024
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
12 Feb 2025, 18:39 IST
Board meeting
12 Feb 2025
Period
01 Oct 2024 to 31 Dec 2024
Review status
Unaudited
Source
XBRL filing on BSE